These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15707518)

  • 21. A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application.
    Silva C; Avelino A; Souto-Moura C; Cruz F
    BJU Int; 2001 Sep; 88(4):355-60. PubMed ID: 11564021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study.
    Kuo HC; Liu HT; Yang WC
    J Urol; 2006 Aug; 176(2):641-5. PubMed ID: 16813911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
    Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
    Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
    Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
    J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.
    Guo C; Yang B; Gu W; Peng B; Xia S; Yang F; Wen D; Geng J; Zhang Y; Zheng J
    PLoS One; 2013; 8(12):e82591. PubMed ID: 24376550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder.
    Chancellor MB; de Groat WC
    J Urol; 1999 Jul; 162(1):3-11. PubMed ID: 10379728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New therapeutic options for refractory neurogenic detrusor overactivity.
    Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M
    Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases.
    Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
    Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing incontinence due to detrusor instability.
    Drug Ther Bull; 2001 Aug; 39(8):59-64. PubMed ID: 11526802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
    Liu HT; Kuo HC
    BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder sensory desensitization decreases urinary urgency.
    Silva C; Silva J; Castro H; Reis F; Dinis P; Avelino A; Cruz F
    BMC Urol; 2007 Jun; 7():9. PubMed ID: 17561998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study.
    Sprem M; Milicić D; Oresković S; Ljubojević N; Kalafatić D
    Croat Med J; 2000 Dec; 41(4):423-7. PubMed ID: 11063767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamic classification of patients with symptoms of overactive bladder.
    Flisser AJ; Walmsley K; Blaivas JG
    J Urol; 2003 Feb; 169(2):529-33; discussion 533-4. PubMed ID: 12544302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
    Rios LA; Panhoca R; Mattos D; Srugi M; Bruschini H
    Neurourol Urodyn; 2007; 26(6):773-8. PubMed ID: 17638305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
    Brady CM; Apostolidis AN; Harper M; Yiangou Y; Beckett A; Jacques TS; Freeman A; Scaravilli F; Fowler CJ; Anand P
    BJU Int; 2004 Apr; 93(6):770-6. PubMed ID: 15049988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder.
    Kim DY; Chancellor MB
    J Endourol; 2000 Feb; 14(1):97-103. PubMed ID: 10735579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravesical treatment of overactive bladder.
    Fowler CJ
    Urology; 2000 May; 55(5A Suppl):60-4; discussion 66. PubMed ID: 10767456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
    Alvares RA; Silva JA; Barboza AL; Monteiro RT
    Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.
    Cruz F
    Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(4):214-20. PubMed ID: 9795827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.